SE8100563L - 17alfa-acyloxi-5beta och 5alfa-kortikoider - Google Patents
17alfa-acyloxi-5beta och 5alfa-kortikoiderInfo
- Publication number
- SE8100563L SE8100563L SE8100563A SE8100563A SE8100563L SE 8100563 L SE8100563 L SE 8100563L SE 8100563 A SE8100563 A SE 8100563A SE 8100563 A SE8100563 A SE 8100563A SE 8100563 L SE8100563 L SE 8100563L
- Authority
- SE
- Sweden
- Prior art keywords
- corticoides
- acyloxi
- 5alfa
- 17alfa
- 5beta
- Prior art date
Links
- 230000000694 effects Effects 0.000 abstract 2
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000009885 systemic effect Effects 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
- C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
- C07J7/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16
- C07J7/0055—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
- C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
- C07J71/0015—Oxiranes at position 9(11)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/117,401 US4318853A (en) | 1980-01-31 | 1980-01-31 | 9β,11β-Epoxy-5β-corticoids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE8100563L true SE8100563L (sv) | 1981-08-01 |
Family
ID=22372732
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8100563A SE8100563L (sv) | 1980-01-31 | 1981-01-28 | 17alfa-acyloxi-5beta och 5alfa-kortikoider |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4318853A (sv) |
| JP (1) | JPS56122398A (sv) |
| KR (1) | KR850001208B1 (sv) |
| AU (1) | AU538883B2 (sv) |
| BE (1) | BE887323A (sv) |
| CA (1) | CA1155108A (sv) |
| CH (1) | CH644614A5 (sv) |
| DE (1) | DE3102397A1 (sv) |
| DK (1) | DK39281A (sv) |
| ES (1) | ES8300342A1 (sv) |
| FR (1) | FR2475048A1 (sv) |
| GB (1) | GB2070016B (sv) |
| GR (1) | GR73511B (sv) |
| IT (1) | IT1193576B (sv) |
| NL (1) | NL8100467A (sv) |
| PH (2) | PH16525A (sv) |
| SE (1) | SE8100563L (sv) |
| ZA (1) | ZA8118B (sv) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3243482A1 (de) * | 1982-11-22 | 1984-05-24 | Schering AG, 1000 Berlin und 4709 Bergkamen | Neue 6(alpha)-methylkortikoide, ihre herstellung und verwendung |
| EP0245357B1 (en) * | 1985-10-23 | 1991-08-07 | The Upjohn Company | Angiostatic steroids |
| NL8900507A (nl) * | 1989-03-02 | 1990-10-01 | Philips Nv | Versterkerschakeling met verzadigingsdetectie. |
| CA2139549A1 (en) * | 1994-01-28 | 1995-07-29 | Kazumi Ogata | Corticoid derivatives and pharmaceutical and cosmetic compositions |
| GB2302807A (en) * | 1995-07-04 | 1997-02-05 | Surtech Int Ltd | Method and composition for treating atopic eczema |
| DE19737348C2 (de) | 1997-08-27 | 2002-07-25 | Dan-Gabriel Vulpescu | Neue Clindamycin und Clotrimazol enthaltende pharmazeutische Zusammensetzung |
| HUE046243T2 (hu) | 2008-05-28 | 2020-02-28 | Reveragen Biopharma Inc | Nem-hormonális NF-KB szteroid modulátorok betegség kezelésére |
| EP2556083A4 (en) | 2010-04-05 | 2013-12-04 | Validus Biopharma Inc | NONHORMONAL STEROID MODULATORS OF NF-KAPPA-B FOR DISEASE TREATMENT |
| CN102225959B (zh) * | 2011-04-29 | 2012-11-07 | 中国科学院上海有机化学研究所 | 一种16β-甲基-17α-羟基孕甾-3,20-二酮化合物及其合成方法 |
| WO2017004205A1 (en) | 2015-06-29 | 2017-01-05 | Reveragen Biopharma, Inc. | NON-HORMONAL STEROID MODULATORS OF NF-κB FOR TREATMENT OF DISEASE |
| US11382922B2 (en) | 2019-03-07 | 2022-07-12 | Reveragen Biopharma, Inc. | Aqueous oral pharmaceutical suspension compositions |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2831874A (en) * | 1954-04-20 | 1958-04-22 | Gnrd Patent Holdings Ltd | Improvements in the preparation of 17:21-diacyloxy-2:4-dibromo-3:11:20-triketoallopregnanes |
| US2854465A (en) * | 1955-02-18 | 1958-09-30 | Ciba Pharm Prod Inc | Process for the manufacture of halogen-pregnanes and dehalogenation products thereof |
| DE1195748B (de) * | 1961-06-24 | 1965-07-01 | Vismara Francesco Spa | Verfahren zur Herstellung von 1'-substituierten 17alpha, 21-(1'-Alkoxy)-methylendioxysterioden |
| US3681410A (en) * | 1970-08-07 | 1972-08-01 | Syntex Corp | Process for preparing 17{60 -hydroxy-20-keto and 17{60 ,21-dihydroxy-20-keto pregnanes and derivatives and intermediates thereof |
-
1980
- 1980-01-31 US US06/117,401 patent/US4318853A/en not_active Expired - Lifetime
-
1981
- 1981-01-02 ZA ZA00810018A patent/ZA8118B/xx unknown
- 1981-01-16 GB GB8101407A patent/GB2070016B/en not_active Expired
- 1981-01-16 CA CA000368713A patent/CA1155108A/en not_active Expired
- 1981-01-21 AU AU66513/81A patent/AU538883B2/en not_active Ceased
- 1981-01-24 PH PH25134A patent/PH16525A/en unknown
- 1981-01-26 GR GR63960A patent/GR73511B/el unknown
- 1981-01-26 DE DE3102397A patent/DE3102397A1/de not_active Withdrawn
- 1981-01-27 IT IT19360/81A patent/IT1193576B/it active
- 1981-01-28 SE SE8100563A patent/SE8100563L/sv not_active Application Discontinuation
- 1981-01-29 ES ES498938A patent/ES8300342A1/es not_active Expired
- 1981-01-29 DK DK39281A patent/DK39281A/da not_active Application Discontinuation
- 1981-01-30 JP JP1178381A patent/JPS56122398A/ja active Pending
- 1981-01-30 FR FR8101828A patent/FR2475048A1/fr active Granted
- 1981-01-30 KR KR1019810000285A patent/KR850001208B1/ko active IP Right Grant
- 1981-01-30 CH CH62681A patent/CH644614A5/de not_active IP Right Cessation
- 1981-01-30 BE BE0/203661A patent/BE887323A/fr not_active IP Right Cessation
- 1981-01-30 NL NL8100467A patent/NL8100467A/nl not_active Application Discontinuation
-
1983
- 1983-06-21 PH PH29092A patent/PH19579A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PH16525A (en) | 1983-11-10 |
| US4318853A (en) | 1982-03-09 |
| BE887323A (fr) | 1981-07-30 |
| PH19579A (en) | 1986-05-26 |
| AU538883B2 (en) | 1984-08-30 |
| GB2070016A (en) | 1981-09-03 |
| FR2475048A1 (fr) | 1981-08-07 |
| JPS56122398A (en) | 1981-09-25 |
| ES498938A0 (es) | 1982-11-01 |
| GB2070016B (en) | 1983-09-14 |
| CA1155108A (en) | 1983-10-11 |
| DE3102397A1 (de) | 1981-12-24 |
| IT8119360A0 (it) | 1981-01-27 |
| AU6651381A (en) | 1981-08-06 |
| FR2475048B1 (sv) | 1984-11-16 |
| NL8100467A (nl) | 1981-09-01 |
| IT1193576B (it) | 1988-07-08 |
| KR850001208B1 (ko) | 1985-08-20 |
| CH644614A5 (de) | 1984-08-15 |
| DK39281A (da) | 1981-08-01 |
| GR73511B (sv) | 1984-03-07 |
| ES8300342A1 (es) | 1982-11-01 |
| ZA8118B (en) | 1982-01-27 |
| KR830005263A (ko) | 1983-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3683894D1 (de) | Optischer verstaerker. | |
| DE3584203D1 (de) | Hochfrequenzleistungsverstaerker mit bipolaren transistoren. | |
| DE3686096D1 (de) | Symmetrischer differenzverstaerker. | |
| ES520522A0 (es) | Perfeccionamientos en las valvulas magneticas con amplificador de potencia. | |
| FI852272L (fi) | Foerbaettringar i och angaoende gasmaskar. | |
| DE3853136D1 (de) | Operationsverstärker mit stabilem Arbeitspunkt. | |
| SE8100563L (sv) | 17alfa-acyloxi-5beta och 5alfa-kortikoider | |
| FR2490896B1 (fr) | Amplificateur d'echantillonnage lineaire a gain eleve | |
| TR19630A (tr) | Stabilize glukos isomerasi enzimi konsentrati ve imaline mahsus usul | |
| DE3680064D1 (de) | Differenzverstaerker-schaltungsanordnung. | |
| IT8026096A0 (it) | Amplificatore con controllo della corrente di incrocio. | |
| DE3667230D1 (de) | Verstaerkeranordnung. | |
| FI850607A0 (fi) | Foerfarande foer avlaegsnande av loesta och i kolloidal form varande stormolekyliga organiska aemnen ur traefoeraedlingsindustrins avfallsvatten. | |
| FR2421510B1 (fr) | Amplificateur isolateur | |
| NL7706358A (nl) | Hoogspanningsversterker. | |
| FI871665A (fi) | Foerfarande foer behandling av smaelt metall och anordning foer utfoerande av foerfarandet. | |
| FI851495L (fi) | Foerfarande och anordning foer aostadkommande av en pao foerhand bestaemd viktfoerdelning i tvaerriktningen av en foermatta och/eller matta. | |
| ES511098A0 (es) | "un amplificador electrico que comprende medios para eliminar los transitorios del voltaje continuo en su salida". | |
| NL178265C (nl) | Antibioticum uit pseudomonas bn-183 en preparaten die dat bevatten. | |
| NL7900567A (nl) | Vermogensversterker. | |
| IT8122729A0 (it) | Disposizione di amplificatore con distorsione bassissima. | |
| DK312483A (da) | Kortikoidholdige praeparater til topisk applikation | |
| DE3672625D1 (de) | Kraftverstaerker. | |
| SU638863A1 (ru) | Пробоотборник | |
| SU658713A1 (ru) | Каскодный усилитель с регулируемым усилением |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAV | Patent application has lapsed |
Ref document number: 8100563-9 |